Home | Alivation Research

Research At Alivation

Dr. Walt Duffy, Founder and Medical Director of Alivation Research, has been the Principal Investigator on over 150 clinical trials since 2005. Alivation could not have done it without the participation of the general public. Take a look at our current studies to see if you are eligible to participate.

Learn More

About

ABOUT US

Alivation Research takes part in research studies that help further science and medicine, and we are constantly looking for qualified candidates to help gather this data. Our goal is to measure results, determine the safety and tolerability of treatment options, and make it possible for our patients to access the newest treatments when traditional treatments may not be working. Participants are often compensated for their time and travel and receive their study medication and devices at no cost.

What do you get out of it?

Compensation from our research sponsors.

Access to new, investigational, treatment options.

A feeling that you have participated in something meaningful.

A chance to contribute to science and your communities.

Current Studies

What Research Studies Do We Currently Offer?

Alivation Research offers both adult and pediatric studies. Each study has their own distinct requirements so be sure to read the indication carefully. If you're interested in learning more, complete the form below and we will be in contact with you soon.

Adult Studies

Study Number 1

--- Indication: Treatment Resistant Depression Investigational Product: Comp360 Age: 19 or older Compensation: $50 to $100 per visit, $500 on treatment day

Study Number 2

--- Indication: Schizophrenia Investigational Product: Valbenazine Age: 19 or older Compensation: $2,100 (max)

Study Number 3

--- Indication: Bipolar Disorder Investigational Product: Vagus Nerve Stimulator Age: 19 or older Compensation: $2,300 (max)

Study Number 4

--- Indication: ADHD Investigational Product: Solriamfetol Age: 19 or older Compensation: $950 (max)

Study Number 5

--- Indication: Major Depressive Disorder Investigational Product: SP-624 Age: 19 or older Compensation: $800 (max)

Pediatric Studies

Study Number 10

--- Indication: Autism Spectrum Disorder Investigational Product: Lumateperone Age: 5 to 12 Compensation: $2,600 (max)

Study Number 11

--- Indication: ADHD Investigational Product: Centanafadine Age: 4 to 5 Compensation: $53 per visit

Study Number 12

--- Indication: Major Depressive Episodes associated with Bipolar Depression Investigational Product: Lumateperone Ages: 10 to 17 Compensation: $1,800 (max)

Study Number 13

--- Indication: Pediatric Schizophrenia Investigational Product: Olanzapine/Samidorphan Ages: 13 to 17 Compensation: $2,100 (max)

Study Number 14

--- Indication: Pediatric Bipolar 1 Disorder Investigational Product: Olanzapine/Samidorphan Ages: 10 to 12 Compensation: $2,100 (max)

Study Number 15

--- Indication: ADHD Investigational Product: Methylphenidate Hydrochloride Ages: 4 to 5 Compensation: TBD

Join a Study

Want to Join a Study?

If you think that you fit any of the requirements for our research studies fill out this form below, which will then be sent to us for review. If you qualify for the research study, we will have a member of our team get back to you on the next steps. To expedite the process, please print the ROI Form and have your healthcare professional complete it.